PROTALIX BIOTHERAPEUTICS INC (PLX)

US74365A3095 - Common Stock

1.25  +0.03 (+2.46%)

Premarket: 1.25 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
65.49M47.64M38.35M62.90M54.69M
Cost Of Goods
22.98M19.59M16.35M10.87M10.90M
Gross Profit
42.51M28.05M22.00M52.03M43.80M
Operating Expenses
32.05M41.06M42.46M49.32M54.51M
Research and Development
17.09M29.35M29.73M38.24M44.69M
Selling, General, and Administrative Expenses
14.96M11.71M12.73M11.15M9.90M
Operating Income
10.46M-13.01M-20.46M2.71M-10.72M
Interest Income/Expense
-1.51M-1.31M-5.03M-7.38M-7.56M
Other Income/Expense
-379.00K-70.00K-2.09M-1.86MN/A
Non Recurring Items
N/AN/AN/AN/A0.00
Income Before Taxes
8.57M-14.40M-27.58M-6.52M-18.28M
Income Tax
254.00K530.00KN/AN/AN/A
Net Income
8.31M-14.93M-27.58M-6.52M-18.28M
EBITDA
11.65M-11.92M-19.34M4.01M-9.10M
 
Per Share Data
EPS Diluted Total Ops
0.10-0.31-0.62-0.22-1.23
Non GAAP EPS
0.05N/A-0.63-0.16-1.18
 
Statistics
Gross Profit Margin
64.91%58.88%57.37%82.72%80.09%
Profit Margin
12.69%-31.34%-71.92%-10.37%-33.42%
Operating Profit Margin
15.97%-27.31%-53.35%4.31%-19.60%

All data in USD

Charts